Apollomics Inc. Class A Ordinary Shares (APLM NASDAQ) stock market data APIs
$16.8301
2.3(13.7%)
as of December 11, 2025
Try our APIs with
free plan!
Apollomics Inc. Class A Ordinary Shares Financial Data Overview
Price chart is built with
Anychart
Apollomics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of oncology therapies to harness the immune system and target specific molecular pathways to inhibit cancer. The company's products portfolio includes Vebreltinib (APL-101), an oral active, highly selective c-Met inhibitor, which is in Phase 2 clinical trials for treatment of non-small cell lung cancer and other solid tumors with MET dysregulation; APL-102, an oral active, small molecule multiple tyrosine kinase inhibitor, which is in a in a Phase 1 clinical trial to inhibit various kinases that are aberrantly activated in cancer cells; and APL-122, a tumor inhibitor candidate, targeting ErbB1/2/4 signaling pathways that is in Phase 1 dose escalation clinical trials to treat cancers within the brain. Its immuno-oncology product candidates comprise APL-501, APL-502, and APL-801. The company was founded in 2015 and is based in Foster City, California.
Prev. Close
16.8301
Open
19.1309
High
19.2998
Low
16.489
52 wk Range
3.659-40.015
Market Cap
44 925 K
Shares Outstanding
2 143 K
Revenue
198 K
EPS
-16.92
Beta
1.811
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Apollomics Inc. Class A Ordinary Shares data using free add-ons & libraries
Get Apollomics Inc. Class A Ordinary Shares Fundamental Data
Apollomics Inc. Class A Ordinary Shares Fundamental data includes:
- Net Revenue: 198 K
- EBITDA: -41 055 000
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-04-03
- EPS/Forecast: -0.15
Get Apollomics Inc. Class A Ordinary Shares End-of-day data
EOD Historical Data package for
$
19.99
/mo.
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Apollomics Inc. Class A Ordinary Shares News
New
Exploring the Evolving Narrative for Nasdaq After Analyst Upgrades and Business Transformation
Nasdaq's fair value estimate has seen a slight increase, rising from $102.35 to $103.13 per share. This adjustment follows a wave of positive analyst sentiment, which is driven by upgraded ratings and...
Apollomics Announces Settlement of Cayman Litigation
FOSTER CITY, Calif., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (“Apollomics” or the “Company”) (Nasdaq: APLM) announced today entering into a settlement agreement (the “Settlement ...
Apollomics Announces Changes to its Board of Directors and Composition of Committees
FOSTER CITY, Calif., Nov. 17, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq: APLM) (“Apollomics” or the “Company”), a California-based late-stage clinical biopharmaceutical company, today...
Apollomics 宣布听证会取消后继续在 Nasdaq 股票市场上市
加利福尼亚州福斯特城, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Apollomics Inc. (Nasdaq 代码：APLM，以下简称 “Apollomics” 或“公司”) 是一家总部位于加利福尼亚州的晚...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
